Titan Pharmaceuticals, Inc. Forms 3, 4 and 5: Other
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 1 rows, 1 shown. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2011-11-21: Reporting owner BHONSLE SUNIL; Form 4; Security A; Transaction Holding.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2011-11-21 holding as of filing | BHONSLE SUNIL Director, Officer (President) | 4 | A Non-derivative · Indirect · By Family Trust | Holding | 250,757 owned after | no price filed | 2011-11-21 |